Stephen B. Baylin

Stephen Baylin is a pioneer in cancer epigenetics who discovered that DNA methylation silences tumor suppressor genes in cancer. His work has led to FDA-approved epigenetic therapies and continues to inform understanding of how epigenetic changes drive cancer development and can be targeted therapeutically.

Stephen Baylin是癌症表观遗传学的先驱，发现了DNA甲基化在癌症中沉默肿瘤抑制基因。他的工作导致了FDA批准的表观遗传疗法，并继续为理解表观遗传变化如何驱动癌症发展以及如何靶向治疗提供信息。